HLA complex
Showing 51 - 75 of 6,451
Study of Eplets Matching in Kidney Transplantation
Active, not recruiting
- Kidney Transplantation
- Eplets mismatching numbers
-
Xi'an, Shaanxi, ChinaThe First Affiliated Hospital of Xi'an Jiaotong University
May 25, 2022
Acute Myeloid Leukemia, MDS, Myeloproliferative Tumor Trial in Boston (CIML NK, Fludarabine, Cyclophosphamide)
Recruiting
- Acute Myeloid Leukemia
- +3 more
- CIML NK
- +2 more
-
Boston, Massachusetts
- +1 more
Jan 6, 2023
Metastatic Uveal Melanoma Trial in Grand Rapids (IDE196, Crizotinib, Pembrolizumab)
Recruiting
- Metastatic Uveal Melanoma
- IDE196
- +5 more
-
Grand Rapids, MichiganThe Cancer and Hematology Centers
Aug 14, 2023
Locoregionally Advanced Head and Neck Squamous Cell Carcinoma (LA-HNSCC) Trial (Monalizumab, Cetuximab)
Not yet recruiting
- Locoregionally Advanced Head and Neck Squamous Cell Carcinoma (LA-HNSCC)
- Monalizumab
- Cetuximab
- (no location specified)
Jan 8, 2023
Resected Pancreatic Adenocarcinoma
Completed
- Pancreatic Cancer Resectable
- Multigene panel for next-generation sequencing
-
Shanghai, Shanghai, ChinaRuijin Hospital
Jul 31, 2022
Nanoparticle for DSA Removal
Recruiting
- Kidney Failure
- Presence of Donor Specific Antibodies
-
Zurich, ZH, SwitzerlandUniversity Hospital Zurich, Division of Anaesthesiology
Mar 11, 2022
Antibody-mediated Rejection, Cardiac Transplant Trial in Rochester (Daratumumab and hyaluronidase-fihj)
Enrolling by invitation
- Antibody-mediated Rejection
- Cardiac Transplant
- Daratumumab and hyaluronidase-fihj
-
Rochester, MinnesotaMayo Clinic Rochester
Apr 11, 2022
Leukemia, Myeloid, Acute Trial in United States (VCAR33)
Not yet recruiting
- Leukemia, Myeloid, Acute
- VCAR33
-
La Jolla, California
- +9 more
Aug 14, 2023
Renal Cell Carcinoma, NSCLC, Pancreatic Adenocarcinoma, Colorectal Cancer Trial (RO7515629, tocilizumab)
Not yet recruiting
- Renal Cell Carcinoma, Non-small Cell Lung Cancer, Pancreatic Adenocarcinoma, Colorectal Cancer
- (no location specified)
Mar 3, 2023
GVHD Trial in Tampa (Cultured Treg cells)
Completed
- Graft Versus Host Disease
- Cultured Treg cells
-
Tampa, FloridaH Lee Moffitt Cancer Center
Nov 2, 2022
Pneumonia, Ventilator-Associated Trial in France (Interferon gamma, Placebo)
Not yet recruiting
- Pneumonia, Ventilator-Associated
- Interferon gamma
- Placebo
-
Lyon, France
- +6 more
May 2, 2023
Platinum-Resistant Fallopian Tube Carcinoma, Platinum-Resistant Ovarian Carcinoma, Platinum-Resistant Primary Peritoneal
Active, not recruiting
- Platinum-Resistant Fallopian Tube Carcinoma
- +11 more
- Aldesleukin
- +3 more
-
Buffalo, New YorkRoswell Park Cancer Institute
Jul 13, 2022
Trifecta-Kidney cfDNA-MMDx Study
Recruiting
- Kidney Transplant Rejection
- MMDx
- +2 more
-
Tampa, Florida
- +30 more
Oct 12, 2022
Advanced Solid Tumor Trial in Beijing (YK0901 cells)
Not yet recruiting
- Advanced Solid Tumor
- YK0901 cells
-
Beijing, ChinaDepartment of GI Oncology, Peking University Cancer Hospital
Jun 27, 2023
Bronchiolitis Obliterans, Lung Transplantation Trial in Brisbane, Perth (MSC)
Completed
- Bronchiolitis Obliterans
- Lung Transplantation
- MSC
-
Brisbane, Queensland, Australia
- +1 more
Apr 19, 2022
Greater Occipital Nerve, Pulsed Radiofrequency Trial in Assiut (proximal ultrasound-guided GON radiofrequency ablation, distal
Completed
- Greater Occipital Nerve
- Pulsed Radiofrequency
- proximal ultrasound-guided GON radiofrequency ablation
- distal ultrasound-guided GON radiofrequency ablation
-
Assiut, EgyptAssiut governorate
Nov 6, 2023
Diabetes, Type 1, Autoimmune Diseases, Prevention Trial in Malmö (Diamyd)
Not yet recruiting
- Diabetes Mellitus, Type 1
- +2 more
-
Malmö, SwedenLund University/CRC, Skåne University Hospital,
Jan 4, 2023
Severe Aplastic Anemia Trial (Busulfan, Flu/Cy/ATG or Cy/ATG)
Not yet recruiting
- Severe Aplastic Anemia
- Busulfan
- Flu/Cy/ATG or Cy/ATG
- (no location specified)
Oct 1, 2023
Axial Spondyloarthritis, Psoriatic Arthritis Trial in Istanbul (serum raftlin-1 protein levels)
Recruiting
- Axial Spondyloarthritis
- Psoriatic Arthritis
- serum raftlin-1 protein levels
-
Istanbul, TurkeyBezmialem University
Mar 22, 2023
Triple Negative Breast Cancer, Metastatic Breast Cancer Trial in Boston (Pembrolizumab, PVX-410)
Active, not recruiting
- Triple Negative Breast Cancer
- Metastatic Breast Cancer
- Pembrolizumab
- PVX-410
-
Boston, Massachusetts
- +2 more
Dec 21, 2022
Synovial Sarcoma, Malignant Peripheral Nerve Sheath Tumor (MPNST), Neuroblastoma Trial in United States (Afamitresgene
Not yet recruiting
- Synovial Sarcoma
- +3 more
- Afamitresgene autoleucel
-
Palo Alto, California
- +3 more
Dec 6, 2022
Ovarian Cancer Trial (Autologous genetically modified ADP-A2M4CD8 cells, Autologous genetically modified ADP-A2M4CD8 cells in
Not yet recruiting
- Ovarian Cancer
- Autologous genetically modified ADP-A2M4CD8 cells
- Autologous genetically modified ADP-A2M4CD8 cells in combination with Nivolumab
- (no location specified)
Jan 31, 2023
Glioma, Malignant Trial in Durham (Tumor Associated Antigen Peptide Vaccine P30-EPS Vaccine, Hiltonol)
Not yet recruiting
- Glioma, Malignant
- Tumor Associated Antigen Peptide Vaccine P30-EPS Vaccine
- Hiltonol
-
Durham, North CarolinaThe Preston Robert Tisch Brain Tumor Center at Duke University
Jan 19, 2023
Pancreatic Cancer, Pancreatic Tumors, Pancreatic Ductal Adenocarcinoma Trial in Shanghai (Cyclophosphamide, Fludarabine, Mutant
Recruiting
- Pancreatic Cancer
- +3 more
- Cyclophosphamide
- +3 more
-
Shanghai, ChinaChanghai Hospital
Jun 13, 2022